SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 2 — Focused Visit (Follow-up) — Harriet Tubman

PatientHarriet Tubman
Date of birth1951-03-01
IdentifiersMRN HR-NI005-SYN; SSN (made up) 000-05-3961
Document date2026-04-20
AuthorCarmen Ruiz-Delgado, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Neurology evaluation of lifelong spells and headache after a head injury. [S]

History of Present Illness

Mrs. Tubman is seen two weeks after her primary care visit for headaches on most days and sudden sleep spells since a severe head injury in her early teens. She stopped daily ibuprofen at that visit. Her headaches were worse for the first several days and have eased since; she has used acetaminophen on no more than 2 days a week and is keeping a headache diary. The spells continue several times a day, often while seated in conversation or at meetings, and end after a few minutes; she wakes and picks up where she left off. Witnesses have described no stiffening, jerking, lip-smacking, tongue biting, or incontinence, and she is not confused afterward. She has never had sudden weakness with laughter or strong emotion. She does not drive. She does not want medicine that makes her duller. [S]

ElementDetail
SpellsSeveral a day, mostly while seated; last a few minutes and end abruptly
Witnessed featuresNo stiffening, jerking, automatisms, tongue biting, incontinence, or confusion afterward
CataplexyNone
Headache since stopping ibuprofenWorse for several days, then easing
Acute medicineAcetaminophen on no more than 2 days a week; no ibuprofen
DrivingDoes not drive
Patient preferenceNo sedating medicine

Review of Systems

SystemResultFinding
NeurologicalPositiveHeadaches most days and sudden sleep spells; no weakness, numbness, or speech change
ConstitutionalNegativeNo fever or weight loss
EyesNegativeNo double vision or visual loss
CardiovascularNegativeNo palpitations, chest pain, or fainting on standing
PsychiatricNegativeMood steady

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ibuprofen 200 mg oral tablet, two tablets by mouth most days (self-directed, over the counter)Two tablets by mouth most daysOral route2025-09-01 to 2026-04-06stoppedS
Acetaminophen 500 mg oral tablet, two tablets by mouth as needed for headache, no more than 2 days a weekTwo tablets by mouth as needed, at most 2 days a weekOral route2026-04-06activeS
Candesartan 8 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-04-20 to 2026-05-18completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-20Body height152cmS
2026-04-20Body weight52kgS
2026-04-20Body mass index (BMI) [Ratio]22.5kg/m2S
2026-04-20Systolic blood pressure140mm[Hg]S
2026-04-20Diastolic blood pressure84mm[Hg]S
2026-04-20Heart rate70/minS
2026-04-20Respiratory rate14/minS
2026-04-20Body temperature36.7CelS
2026-04-20Oxygen saturation in Arterial blood by Pulse oximetry98%S

Physical Exam

Vital signs recorded on 2026-04-20; see the Vital Signs section. [S]

SystemFinding
GeneralAlert and engaged; no spell during the visit
HeadPalpable depression of the left frontal skull, healed
FundiSharp discs; no papilledema
Cranial nervesIntact
Motor and sensoryNormal strength, tone, and sensation
Coordination and gaitNormal finger-nose testing and gait
ReflexesSymmetric

Problems

ProblemClinical statusVerificationCodeProvenance
Chronic post-traumatic headache since an adolescent head injuryactiveconfirmed G44.329S — Synthetic modern coding of the documented lifelong headaches.
Medication-overuse headache from near-daily ibuprofen, resolved after withdrawalresolvedconfirmed G44.40S — Synthetic finding; resolved by the three-month review.
Sequelae of a traumatic brain injury in adolescence, a skull fracture by historical accountactiveconfirmed S06.9XASS — Synthetic modern coding of the documented injury; the MRI findings in the episode are synthetic.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ReferralNeurology evaluation of possible seizuresAfter a first or uncertain seizureCompleted todaySeen today
ExaminationRoutine EEGAfter a possible seizureCompleted todayIntermittent left frontal slowing; no epileptiform discharges
ImagingMRI of the brainAfter a possible seizureCompleted todayOld depressed left frontal skull defect with small encephalomalacia; normal hippocampi; no tumor
ExaminationAmbulatory EEG with video to capture typical spellsWhen routine EEG is not diagnosticOrderedBooked for early next month
ExaminationOvernight polysomnography and multiple sleep latency testFor excessive daytime sleepinessOrderedBooked after the ambulatory EEG
SurveyPROMIS sleep-related impairmentAt baseline and after treatmentUp to dateT-score 68 two weeks ago; repeat at the results visit
Medication safetyAntiseizure medicineOnly if spells prove epilepticNot indicatedNot started; awaiting the ambulatory EEG
Self-managementHeadache diary (headache days and acute-medicine days)DailyCompleted todayStarted two weeks ago and reviewed today
Medication safetyAcute headache medicine on no more than 2 days a weekEvery visitCompleted todayNo ibuprofen since the first visit; acetaminophen within the limit
SurveyHeadache days per three monthsAt baseline and 2 to 3 months after starting preventionUp to date54 days in the three months before intake; reassess at the three-month review
ExaminationBlood pressure, heart rate, and weightEvery visitCompleted today140/84 mmHg, pulse 70, weight 52 kg; baseline before candesartan
LaboratoryBasic metabolic panel (potassium and creatinine) on candesartanBefore starting and a few weeks after; then periodicallyUp to dateBaseline two weeks ago: potassium 4.2, creatinine 0.84, eGFR 72. Recheck in four weeks
Self-managementSafety advice for sudden sleep episodesEvery visitCompleted todayReviewed with her today; she does not drive
SurveyDepression screen (PHQ-9)At baseline and at follow-upUp to dateScore 3 at intake; repeat at the three-month review

Goal progress:

Guideline basis: Evidence-based guideline: Management of an unprovoked first seizure in adults (Krumholz A, et al. Neurology 2015;84(16):1705-1713) (2015); Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline (Maski K, et al. J Clin Sleep Med 2021;17(9):1881-1893) (2021); The International Classification of Headache Disorders, 3rd edition (Cephalalgia 2018;38(1):1-211) (2018); The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice (Ailani J, et al. Headache 2021;61(7):1021-1039) (2021)

Follow-up: Ambulatory EEG, then polysomnography and a multiple sleep latency test. Results visit with potassium and creatinine in four weeks. Next scheduled visit 2026-05-18: review of ambulatory EEG and sleep studies; four-week headache check. [S]